Harmonization: a methodology for advancing research in multiple sclerosis.

Area of Science:

• Epidemiology
• Biostatistics
• Neuroscience

Background:

• Research funding limitations conflict with the need for large-scale studies to investigate rare risk factors and their interactions.
• Multiple sclerosis (MS) is a multifactorial disease requiring substantial participant numbers to analyze risk factor interactions and subgroup-specific effects.
• Current research practices face challenges in maximizing investments due to increasing study demands.

Purpose of the Study:

• To introduce the concept and methodology of data harmonization.
• To illustrate the potential advantages of harmonization in multiple sclerosis (MS) research.
• To address the need for strategies that enhance research efficiency and sample size.

Main Methods:

• Harmonization is presented as a methodological approach to systematically combine individual data from multiple observational studies.
• The process involves standardizing data collection and variable definitions across studies to ensure comparability.
• Quality assessment of individual studies and construct comparability are highlighted as critical for robust harmonized results.

Main Results:

• Combining data through harmonization increases overall sample size, enabling the examination of rare risk factors and complex interactions.
• Harmonization facilitates the analysis of risk factors within specific subgroups, which is crucial for multifactorial diseases like MS.
• The quality of harmonized data is contingent upon the quality and comparability of the source studies.

Conclusions:

• Harmonization offers a viable strategy to overcome funding limitations and enhance the statistical power of observational studies.
• This methodology is particularly advantageous for complex diseases such as multiple sclerosis, where large sample sizes are essential.
• Implementing harmonization can maximize research investments and advance our understanding of disease etiology.